First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system
- PMID: 17724160
- PMCID: PMC2151438
- DOI: 10.1128/AAC.00576-07
First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system
Erratum in
- Antimicrob Agents Chemother. 2008 Feb;52(2):810
Abstract
CTX-M-type extended-spectrum beta-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in Escherichia coli isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing E. coli, which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing Klebsiella spp. was not helpful with initial recognition. CTX-M enzymes were also identified in Proteus mirabilis, Enterobacter spp., and Morganella morganii. Based on pulsed-field gel electrophoresis typing of the E. coli isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.
Figures
Similar articles
-
Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.J Clin Microbiol. 2005 Sep;43(9):4486-91. doi: 10.1128/JCM.43.9.4486-4491.2005. J Clin Microbiol. 2005. PMID: 16145096 Free PMC article.
-
Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.Microb Drug Resist. 2010 Mar;16(1):55-60. doi: 10.1089/mdr.2009.0107. Microb Drug Resist. 2010. PMID: 20001741
-
Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.Microb Drug Resist. 2010 Mar;16(1):49-53. doi: 10.1089/mdr.2009.0096. Microb Drug Resist. 2010. PMID: 19961397
-
The spread of CTX-M-type extended-spectrum beta-lactamases.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41. doi: 10.1111/j.1469-0691.2007.01867.x. Clin Microbiol Infect. 2008. PMID: 18154526 Review.
-
Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.J Microbiol Immunol Infect. 2006 Aug;39(4):264-77. J Microbiol Immunol Infect. 2006. PMID: 16926972 Review.
Cited by
-
Molecular Epidemiology of Dairy Cattle-Associated Escherichia coli Carrying blaCTX-M Genes in Washington State.Appl Environ Microbiol. 2018 Mar 1;84(6):e02430-17. doi: 10.1128/AEM.02430-17. Print 2018 Mar 15. Appl Environ Microbiol. 2018. PMID: 29305512 Free PMC article.
-
CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States.Emerg Infect Dis. 2011 Jan;17(1):97-9. doi: 10.3201/eid1701.100511. Emerg Infect Dis. 2011. PMID: 21192864 Free PMC article.
-
CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales.JAC Antimicrob Resist. 2021 May 7;3(2):dlab020. doi: 10.1093/jacamr/dlab020. eCollection 2021 Jun. JAC Antimicrob Resist. 2021. PMID: 34223109 Free PMC article.
-
Recent Emergence of Escherichia coli with Cephalosporin Resistance Conferred by blaCTX-M on Washington State Dairy Farms.Appl Environ Microbiol. 2015 Jul;81(13):4403-10. doi: 10.1128/AEM.00463-15. Epub 2015 Apr 24. Appl Environ Microbiol. 2015. PMID: 25911480 Free PMC article.
-
Epidemic Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in the Pediatric Intensive Care Unit of Yanbian University Hospital, China.Infect Drug Resist. 2020 May 18;13:1439-1446. doi: 10.2147/IDR.S245397. eCollection 2020. Infect Drug Resist. 2020. PMID: 32547112 Free PMC article.
References
-
- Ben-Ami, R., M. J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, A. Leavitt, and Y. Carmeli. 2006. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934. - PubMed
-
- Bratu, S., S. Brooks, S. Burney, S. Kochar, J. Gupta, D. Landman, and J. Quale. 2007. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975. - PubMed
-
- Burgess, D. S., R. G. Hall II, J. S. Lewis II, J. H. Jorgensen, and J. E. Patterson. 2003. Clinical and microbiologic analysis of a hospital's extended-spectrum β-lactamase-producing isolates over a 2-year period. Pharmacotherapy 23:1232-1237. - PubMed
-
- Clinical and Laboratory Standards Institute. 2007. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous